Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Naoual Benali-Furet"'
Autor:
Laura Nalleli Garrido Castillo, Arnaud Mejean, Philippe Vielh, Julien Anract, Alessandra Decina, Bertrand Nalpas, Naoual Benali-Furet, Isabelle Desitter, Patrizia Paterlini-Bréchot
Publikováno v:
Life, Vol 12, Iss 2, p 165 (2022)
There is an unmet need for reliable biomarkers to predict prostate cancer recurrence after prostatectomy in order to better guide the choice of surgical treatment. We have evaluated the predictive value of the preoperative detection of Circulating Tu
Externí odkaz:
https://doaj.org/article/d168b6d70cd943918edb5bafd4281f1e
Autor:
Jérôme Alexandre Denis, Alexia Patroni, Erell Guillerm, Dominique Pépin, Naoual Benali-Furet, Janine Wechsler, Gilles Manceau, Maguy Bernard, Florence Coulet, Annette K. Larsen, Mehdi Karoui, Jean-Marc Lacorte
Publikováno v:
Molecular Oncology, Vol 10, Iss 8, Pp 1221-1231 (2016)
In colorectal cancer (CRC), KRAS mutations are a strong negative predictor for treatment with the EGFR‐targeted antibodies cetuximab and panitumumab. Since it can be difficult to obtain appropriate tumor tissues for KRAS genotyping, alternative met
Externí odkaz:
https://doaj.org/article/c3706c07b9d94c6ca64428ed30c982ae
Autor:
Julius Adebayo Awe, Mark Chu Xu, Janine Wechsler, Naoual Benali-Furet, Yvon E. Cayre, Jeff Saranchuk, Darrel Drachenberg, Sabine Mai
Publikováno v:
Translational Oncology, Vol 6, Iss 1, Pp 51IN4-65 (2013)
Circulating tumor cells (CTCs) have been identified with the potential to serve as suitable biomarkers for tumor stage and progression, but the availability of effective isolation technique(s) coupled with detailed molecular characterization have bee
Externí odkaz:
https://doaj.org/article/fd5bf59a1a5b44808e14aba26e7df437
Autor:
Carmela Paolillo, Anaëlle Znaty, Zhong Ye, Giovanna Rossi, Chun Wang, Paolo Fortina, Zhaomei Mu, Massimo Cristofanilli, Laura Austin, Naoual Benali-Furet, Georges Uzan, Hushan Yang
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 17; Issue 10; Pages: 1665
International Journal of Molecular Sciences, Vol 17, Iss 10, p 1665 (2016)
International Journal of Molecular Sciences; Volume 17; Issue 10; Pages: 1665
International Journal of Molecular Sciences, Vol 17, Iss 10, p 1665 (2016)
The availability of blood-based diagnostic testing using a non-invasive technique holds promise for real-time monitoring of disease progression and treatment selection. Circulating tumor cells (CTCs) have been used as a prognostic biomarker for the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57d27127caaf5c75bf9a351275b337be
http://europepmc.org/articles/PMC5085698
http://europepmc.org/articles/PMC5085698
Autor:
Alexia Patroni, Janine Wechsler, Erell Guillerm, Maguy Bernard, Jean-Marc Lacorte, Mehdi Karoui, Florence Coulet, Jérôme Alexandre Denis, Naoual Benali-Furet, Gilles Manceau, Annette K. Larsen, Dominique Pepin
Publikováno v:
Molecular Oncology
Molecular Oncology, Elsevier, 2016, 10 (8), pp.1221-1231. ⟨10.1016/j.molonc.2016.05.009⟩
Molecular Oncology, 2016, 10 (8), pp.1221-1231. ⟨10.1016/j.molonc.2016.05.009⟩
Molecular Oncology, Elsevier, 2016, 10 (8), pp.1221-1231. ⟨10.1016/j.molonc.2016.05.009⟩
Molecular Oncology, 2016, 10 (8), pp.1221-1231. ⟨10.1016/j.molonc.2016.05.009⟩
International audience; In colorectal cancer (CRC), KRAS mutations are a strong negative predictor for treatment with the EGFR-targeted antibodies cetuximab and panitumumab. Since it can be difficult to obtain appropriate tumor tissues for KRAS genot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5e6cba3d36fcb1ee0ea74524ae0b3bf
https://hal.sorbonne-universite.fr/hal-01331243
https://hal.sorbonne-universite.fr/hal-01331243
Autor:
Mark Chu Xu, Janine Wechsler, Darrel Drachenberg, Julius Adebayo Awe, Yvon E. Cayre, Jeff Saranchuk, Sabine Mai, Naoual Benali-Furet
Publikováno v:
Translational Oncology
Translational Oncology, 2013, 6 (1), pp.51-65. ⟨10.1593/tlo.12361⟩
Translational Oncology, Elsevier, 2013, 6 (1), pp.51-65. ⟨10.1593/tlo.12361⟩
Translational Oncology, Vol 6, Iss 1, Pp 51IN4-65 (2013)
Translational Oncology, 2013, 6 (1), pp.51-65. ⟨10.1593/tlo.12361⟩
Translational Oncology, Elsevier, 2013, 6 (1), pp.51-65. ⟨10.1593/tlo.12361⟩
Translational Oncology, Vol 6, Iss 1, Pp 51IN4-65 (2013)
International audience; Circulating tumor cells (CTCs) have been identified with the potential to serve as suitable biomarkers for tumor stage and progression, but the availability of effective isolation technique(s) coupled with detailed molecular c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4febb40bae1020a834f790c87771aa46
https://hal.sorbonne-universite.fr/hal-01535755/document
https://hal.sorbonne-universite.fr/hal-01535755/document
Autor:
Isabelle, Desitter, Bella S, Guerrouahen, Naoual, Benali-Furet, Janine, Wechsler, Pasi A, Jänne, Yanan, Kuang, Masahiko, Yanagita, Lilin, Wang, Jillian A, Berkowitz, Robert J, Distel, Yvon E, Cayre
Publikováno v:
Anticancer research. 31(2)
Circulating tumor cells (CTCs) likely derive from clones in the primary tumor, suggesting that they can be used for all biological tests applying to the primary cells.The ScreenCell® devices are single-use and low-cost innovative devices that use a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b4482d73b1900ca7207258a2a3448837
https://pubmed.ncbi.nlm.nih.gov/21378321
https://pubmed.ncbi.nlm.nih.gov/21378321
Autor:
Janine Wechsler, Pasquale F. Innominato, Jean F. Morere, Fei Ye, Mazen Haydar, Naoual Benali-Furet, Ayhan Ulusakarya, Georges Uzan
Publikováno v:
Journal of Clinical Oncology. 33:e22039-e22039
e22039 Background: CTCs are considered as useful indicators of tumor aggressiveness, patient prognosis, and treatment effectiveness monitoring. Detection of CTCs in blood is difficult due to the ex...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::006aec040b0e6af9415eb6ef2519ace7
https://doi.org/10.1200/jco.2015.33.15_suppl.e22039
https://doi.org/10.1200/jco.2015.33.15_suppl.e22039
Autor:
Naoual Benali-Furet, Fei Ye, Yvon E. Cayre, Marie Odile North, Janine Wechsler, Agnès Carlotti, Isbou Paraiso, F. Boitier, Marie-Françoise Avril, Eric Clauser
Publikováno v:
Journal of Clinical Oncology. 30:e21014-e21014
e21014 Background: The efficacy of anti-BRAF therapies in patients with melanoma has emphasized the need to identify BRAF mutations in the tumour. As circulating tumour cells (CTC) derive from the primary tumour (PT), their analysis may represent a n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e872d0e8af1c0a1f327730a988fcfe3b
https://doi.org/10.1200/jco.2012.30.15_suppl.e21014
https://doi.org/10.1200/jco.2012.30.15_suppl.e21014
Autor:
Marie-Françoise Avril, Janine Wechsler, Sarah Ezaoui, Fei Ye, Agnès Carlotti, F. Boitier, Isbou Paraiso, Yvon E. Cayre, Naoual Benali-Furet
Publikováno v:
Journal of Clinical Oncology. 30:e21046-e21046
e21046 Background: To date there are no studies demonstrating the ability of circulating tumor cells (CTCs) isolated from patients to grow ex-vivo in culture. Most of our knowledge on the mechanisms of cancer metastasis has been obtained from CTCs of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39e36d321aef0df9bc82a97b737cc6e3
https://doi.org/10.1200/jco.2012.30.15_suppl.e21046
https://doi.org/10.1200/jco.2012.30.15_suppl.e21046